{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:23:14Z","timestamp":1792754594045,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-024-03735-y","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T08:02:41Z","timestamp":1730793761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["METTL3 facilitates kidney injury through promoting IRF4-mediated plasma cell infiltration via an m6A-dependent manner in systemic lupus erythematosus"],"prefix":"10.1186","volume":"22","author":[{"given":"Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingcheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weinian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"issue":"11","key":"3735_CR1","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. Ann Intern Med. 2020;172(11):ITC81\u201396.","journal-title":"Ann Intern Med"},{"issue":"5","key":"3735_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/0961203309358187","volume":"19","author":"LM Ortega","year":"2010","unstructured":"Ortega LM, Schultz DR, Lenz O, Pardo V, Contreras GN. Review: lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus. 2010;19(5):557\u201374.","journal-title":"Lupus"},{"issue":"1","key":"3735_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","volume":"6","author":"HJ Anders","year":"2020","unstructured":"Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers. 2020;6(1):7.","journal-title":"Nat Rev Dis Primers"},{"key":"3735_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaut.2016.06.006","volume":"74","author":"G Moroni","year":"2016","unstructured":"Moroni G, Depetri F, Ponticelli C. Lupus nephritis: when and how often to biopsy and what does it mean? J Autoimmun. 2016;74:27\u201340.","journal-title":"J Autoimmun"},{"issue":"7","key":"3735_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","volume":"23","author":"VR Moulton","year":"2017","unstructured":"Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC. Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med. 2017;23(7):615\u201335.","journal-title":"Trends Mol Med"},{"issue":"1","key":"3735_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/ndt\/gfy267","volume":"34","author":"S Almaani","year":"2019","unstructured":"Almaani S, Rovin BH. B-cell therapy in lupus nephritis: an overview. Nephrol Dial Transplant. 2019;34(1):22\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"3735_CR7","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.4049\/jimmunol.172.6.3913","volume":"172","author":"H Sekine","year":"2004","unstructured":"Sekine H, Watanabe H, Gilkeson GS. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL\/MpJ-Fas(lpr) mice. J Immunol. 2004;172(6):3913\u201321.","journal-title":"J Immunol"},{"issue":"2","key":"3735_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1681\/ASN.2010050515","volume":"22","author":"M Espeli","year":"2011","unstructured":"Espeli M, Bokers S, Giannico G, Dickinson HA, Bardsley V, Fogo AB, et al. Local renal autoantibody production in lupus nephritis. J Am Soc Nephrol. 2011;22(2):296\u2013305.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"3735_CR9","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","volume":"165","author":"M Odendahl","year":"2000","unstructured":"Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol. 2000;165(10):5970\u20139.","journal-title":"J Immunol"},{"issue":"2","key":"3735_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jim.2010.06.009","volume":"363","author":"T Dorner","year":"2011","unstructured":"Dorner T, Jacobi AM, Lee J, Lipsky PE. Abnormalities of B cell subsets in patients with systemic lupus erythematosus. J Immunol Methods. 2011;363(2):187\u201397.","journal-title":"J Immunol Methods"},{"issue":"7","key":"3735_CR11","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41423-020-00540-4","volume":"18","author":"K Ma","year":"2021","unstructured":"Ma K, Du W, Xiao F, Han M, Huang E, Peng N, et al. IL-17 sustains the plasma cell response via p38-mediated Bcl-xL RNA stability in lupus pathogenesis. Cell Mol Immunol. 2021;18(7):1739\u201350.","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"3735_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41584-023-00948-y","volume":"19","author":"S Fasano","year":"2023","unstructured":"Fasano S, Milone A, Nicoletti GF, Isenberg DA, Ciccia F. Precision medicine in systemic lupus erythematosus. Nat Rev Rheumatol. 2023;19(6):331\u201342.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3735_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41392-021-00725-x","volume":"6","author":"M Yang","year":"2021","unstructured":"Yang M, Long D, Hu L, Zhao Z, Li Q, Guo Y, et al. AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation. Signal Transduct Target Ther. 2021;6(1):341.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"3735_CR14","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Hsu PJ, Chen YS, Yang YG. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28(6):616\u201324.","journal-title":"Cell Res"},{"issue":"1","key":"3735_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74.","journal-title":"Signal Transduct Target Ther"},{"issue":"7743","key":"3735_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","volume":"566","author":"D Han","year":"2019","unstructured":"Han D, Liu J, Chen C, Dong L, Liu Y, Chang R, et al. Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells. Nature. 2019;566(7743):270\u20134.","journal-title":"Nature"},{"issue":"5","key":"3735_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41590-020-0650-4","volume":"21","author":"Z Shulman","year":"2020","unstructured":"Shulman Z, Stern-Ginossar N. The RNA modification N(6)-methyladenosine as a novel regulator of the immune system. Nat Immunol. 2020;21(5):501\u201312.","journal-title":"Nat Immunol"},{"issue":"4","key":"3735_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jcmgh.2020.07.001","volume":"10","author":"TX Lu","year":"2020","unstructured":"Lu TX, Zheng Z, Zhang L, Sun HL, Bissonnette M, Huang H, et al. A New Model of Spontaneous Colitis in Mice Induced by Deletion of an RNA m(6)A Methyltransferase Component METTL14 in T Cells. Cell Mol Gastroenterol Hepatol. 2020;10(4):747\u201361.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"3735_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/cr.2018.7","volume":"28","author":"J Tong","year":"2018","unstructured":"Tong J, Cao G, Zhang T, Sefik E, Amezcua Vesely MC, Broughton JP, et al. m(6)A mRNA methylation sustains Treg suppressive functions. Cell Res. 2018;28(2):253\u20136.","journal-title":"Cell Res"},{"issue":"13","key":"3735_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107819","volume":"31","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Zhang L, Cui XL, Yu X, Hsu PJ, Lyu R, et al. Control of Early B Cell Development by the RNA N(6)-Methyladenosine Methylation. Cell Rep. 2020;31(13): 107819.","journal-title":"Cell Rep"},{"issue":"1","key":"3735_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12575-021-00152-w","volume":"23","author":"ZL Yu","year":"2021","unstructured":"Yu ZL, Zhu ZM. N6-methyladenosine related long non-coding rnas and immune cell infiltration in the tumor microenvironment of gastric cancer. Biol Proced Online. 2021;23(1):15.","journal-title":"Biol Proced Online"},{"issue":"19","key":"3735_CR22","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1016\/j.molcel.2021.07.037","volume":"81","author":"L Nair","year":"2021","unstructured":"Nair L, Zhang W, Laffleur B, Jha MK, Lim J, Lee H, et al. Mechanism of noncoding RNA-associated N(6)-methyladenosine recognition by an RNA processing complex during IgH DNA recombination. Mol Cell. 2021;81(19):3949-64 e7.","journal-title":"Mol Cell"},{"issue":"9","key":"3735_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1298","volume":"8","author":"Q Luo","year":"2020","unstructured":"Luo Q, Rao J, Zhang L, Fu B, Guo Y, Huang Z, et al. The study of METTL14, ALKBH5, and YTHDF2 in peripheral blood mononuclear cells from systemic lupus erythematosus. Mol Genet Genomic Med. 2020;8(9): e1298.","journal-title":"Mol Genet Genomic Med"},{"key":"3735_CR24","doi-asserted-by":"publisher","first-page":"8193895","DOI":"10.1155\/2020\/8193895","volume":"2020","author":"Q Luo","year":"2020","unstructured":"Luo Q, Fu B, Zhang L, Guo Y, Huang Z, Li J. Decreased Peripheral Blood ALKBH5 Correlates with Markers of Autoimmune Response in Systemic Lupus Erythematosus. Dis Markers. 2020;2020:8193895.","journal-title":"Dis Markers"},{"issue":"27","key":"3735_CR25","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.2174\/1381612828666220617154204","volume":"28","author":"LJ Deng","year":"2022","unstructured":"Deng LJ, Fang XY, Wu J, Li QR, Mao YM, Leng RX, et al. ALKBH5 Expression could Affect the Function of T Cells in Systemic Lupus Erythematosus Patients: A Case-control Study. Curr Pharm Des. 2022;28(27):2270\u20138.","journal-title":"Curr Pharm Des"},{"key":"3735_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.752736","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao X, Ge L, Wang J, Song Z, Ni B, He X, et al. Exploration of Potential Integrated Models of N6-Methyladenosine Immunity in Systemic Lupus Erythematosus by Bioinformatic Analyses. Front Immunol. 2021;12: 752736.","journal-title":"Front Immunol"},{"key":"3735_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molimm.2022.01.006","volume":"143","author":"J Wu","year":"2022","unstructured":"Wu J, Deng LJ, Xia YR, Leng RX, Fan YG, Pan HF, et al. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus. Mol Immunol. 2022;143:77\u201384.","journal-title":"Mol Immunol"},{"issue":"1","key":"3735_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13075-022-02732-x","volume":"24","author":"X Zhao","year":"2022","unstructured":"Zhao X, Dong R, Zhang L, Guo J, Shi Y, Ge L, et al. N6-methyladenosine-dependent modification of circGARS acts as a new player that promotes SLE progression through the NF-kappaB\/A20 axis. Arthritis Res Ther. 2022;24(1):37.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"3735_CR29","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3735_CR30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35(6):630\u201340.","journal-title":"Arthritis Rheum"},{"issue":"640","key":"3735_CR31","doi-asserted-by":"publisher","first-page":"eabk2709","DOI":"10.1126\/scitranslmed.abk2709","volume":"14","author":"JN Wang","year":"2022","unstructured":"Wang JN, Wang F, Ke J, Li Z, Xu CH, Yang Q, et al. Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms. Sci Transl Med. 2022;14(640):eabk2709.","journal-title":"Sci Transl Med"},{"issue":"1","key":"3735_CR32","doi-asserted-by":"publisher","first-page":"e000870","DOI":"10.1136\/lupus-2022-000870","volume":"10","author":"S Sato","year":"2023","unstructured":"Sato S, Zhang XK, Matsuoka N, Sumichika Y, Saito K, Yoshida S, et al. Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL\/lpr mouse. Lupus Sci Med. 2023;10(1):e000870.","journal-title":"Lupus Sci Med"},{"issue":"6","key":"3735_CR33","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.cmet.2021.03.024","volume":"33","author":"H Ramalingam","year":"2021","unstructured":"Ramalingam H, Kashyap S, Cobo-Stark P, Flaten A, Chang CM, Hajarnis S, et al. A methionine-Mettl3-N(6)-methyladenosine axis promotes polycystic kidney disease. Cell Metab. 2021;33(6):1234-47 e7.","journal-title":"Cell Metab."},{"issue":"8","key":"3735_CR34","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/rheumatology\/keh688","volume":"44","author":"G Riemekasten","year":"2005","unstructured":"Riemekasten G, Hahn BH. Key autoantigens in SLE. Rheumatology (Oxford). 2005;44(8):975\u201382.","journal-title":"Rheumatology (Oxford)"},{"key":"3735_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molimm.2017.11.009","volume":"93","author":"LJ Li","year":"2018","unstructured":"Li LJ, Fan YG, Leng RX, Pan HF, Ye DQ. Potential link between m(6)A modification and systemic lupus erythematosus. Mol Immunol. 2018;93:55\u201363.","journal-title":"Mol Immunol"},{"issue":"5","key":"3735_CR36","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.3390\/ijms24054721","volume":"24","author":"S Wang","year":"2023","unstructured":"Wang S, Li H, Lian Z, Deng S. The Role of m(6)A Modifications in B-Cell Development and B-Cell-Related Diseases. Int J Mol Sci. 2023;24(5):4721.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3735_CR37","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41556-019-0318-1","volume":"21","author":"H Lee","year":"2019","unstructured":"Lee H, Bao S, Qian Y, Geula S, Leslie J, Zhang C, et al. Stage-specific requirement for Mettl3-dependent m(6)A mRNA methylation during haematopoietic stem cell differentiation. Nat Cell Biol. 2019;21(6):700\u20139.","journal-title":"Nat Cell Biol"},{"key":"3735_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.724837","volume":"9","author":"H Zhao","year":"2021","unstructured":"Zhao H, Pan S, Duan J, Liu F, Li G, Liu D, et al. Integrative Analysis of m(6)A Regulator-Mediated RNA Methylation Modification Patterns and Immune Characteristics in Lupus Nephritis. Front Cell Dev Biol. 2021;9: 724837.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"3735_CR39","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.4049\/jimmunol.1701385","volume":"199","author":"J Hagman","year":"2017","unstructured":"Hagman J. Critical Functions of IRF4 in B and T Lymphocytes. J Immunol. 2017;199(11):3715\u20136.","journal-title":"J Immunol"},{"key":"3735_CR40","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.3389\/fimmu.2018.03085","volume":"9","author":"J Rodriguez-Carrio","year":"2018","unstructured":"Rodriguez-Carrio J, Lopez P, Alperi-Lopez M, Caminal-Montero L, Ballina-Garcia FJ, Suarez A. IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis. Front Immunol. 2018;9:3085.","journal-title":"Front Immunol"},{"issue":"1","key":"3735_CR41","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41392-023-01413-8","volume":"8","author":"S He","year":"2023","unstructured":"He S, Ding H, Chen L, Shen Y, Liu Y, Zhu F, et al. Repression of interferon regulatory factor-4 (IRF4) hyperactivation restricts murine lupus. Signal Transduct Target Ther. 2023;8(1):188.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"3735_CR42","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1681\/ASN.2010121260","volume":"22","author":"M Lech","year":"2011","unstructured":"Lech M, Weidenbusch M, Kulkarni OP, Ryu M, Darisipudi MN, Susanti HE, et al. IRF4 deficiency abrogates lupus nephritis despite enhancing systemic cytokine production. J Am Soc Nephrol. 2011;22(8):1443\u201352.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"3735_CR43","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1172\/JCI24096","volume":"116","author":"JC Fanzo","year":"2006","unstructured":"Fanzo JC, Yang W, Jang SY, Gupta S, Chen Q, Siddiq A, et al. Loss of IRF-4-binding protein leads to the spontaneous development of systemic autoimmunity. J Clin Invest. 2006;116(3):703\u201314.","journal-title":"J Clin Invest"},{"issue":"6","key":"3735_CR44","first-page":"3220","volume":"42","author":"SP Xu","year":"2018","unstructured":"Xu SP, Li YS. Fisetin inhibits pristine-induced systemic lupus erythematosus in a murine model through CXCLs regulation. Int J Mol Med. 2018;42(6):3220\u201330.","journal-title":"Int J Mol Med"},{"key":"3735_CR45","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.12659\/MSM.900754","volume":"23","author":"Q Wang","year":"2017","unstructured":"Wang Q, Yan C, Xin M, Han L, Zhang Y, Sun M. Sirtuin 1 (Sirt1) Overexpression in BaF3 Cells Contributes to Cell Proliferation Promotion, Apoptosis Resistance and Pro-Inflammatory Cytokine Production. Med Sci Monit. 2017;23:1477\u201382.","journal-title":"Med Sci Monit"},{"issue":"10","key":"3735_CR46","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/intimm\/dxaa042","volume":"32","author":"K Fujii","year":"2020","unstructured":"Fujii K, Tanaka S, Hasegawa T, Narazaki M, Kumanogoh A, Koseki H, et al. Tet DNA demethylase is required for plasma cell differentiation by controlling expression levels of IRF4. Int Immunol. 2020;32(10):683\u201390.","journal-title":"Int Immunol"},{"issue":"10","key":"3735_CR47","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/ni.3519","volume":"17","author":"BG Barwick","year":"2016","unstructured":"Barwick BG, Scharer CD, Bally APR, Boss JM. Plasma cell differentiation is coupled to division-dependent DNA hypomethylation and gene regulation. Nat Immunol. 2016;17(10):1216\u201325.","journal-title":"Nat Immunol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03735-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-024-03735-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03735-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:04:58Z","timestamp":1730837098000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-024-03735-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3735"],"URL":"https:\/\/doi.org\/10.1186\/s12916-024-03735-y","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Seventh Affiliated Hospital of Sun Yat-sen University, and all patients and healthy volunteers signed informed consent (Approval Number: 2019SYSUSH-037). Animal experiments have been approved by the Animal Experiment Ethics Committee of Sun Yat-sen University (Approval Number: SYSU-IACUC-2022\u2013000413).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients and healthy donors in this study signed an informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"511"}}